METTL14-Mediate the Biological Effects of EMT in Bladder Cancer Cells by Methylating SOX4 mRNA with m6A

ABSTRACT

Objectives Bladder Cancer (BC) is one of the most common malignant tumours of urinary system, with high rates of metastasis and mortality. Methyltransferase-like 14 (METTL14) is an RNA N6-adenosine methyltransferase that can affect the development of tumours by modifying RNA expression. The study aims to uncover the molecular mechanism and biological function of METTLI4 in BC. Materials and Methods qRT-PCR assays were employed METTL14 in BC cell lines. MeRIP-qPCR and RIP were used to verify that SRY-related high-mobility-group box 4 (SOX4) modification by m6A is a downstream target of METTL14. Results Biological experiments in vitro have demonstrated the biological function of METTL14 on BC cells. In the MGH-U3 cell lines, the expression of METTL14 was significantly down-regulated (p < 0.001), while the expression of SOX4 was significantly up-regulated (p < 0.01). Intervention of METTL14 expression can affect cell proliferation, migration, invasion, apoptosis, as well as the expression of EMT proteins in BC cell lines (p < 0.05). In addition, METTL14 can affect the biological functions of MGH-U3 cells and the expression of EMT proteins through the m6A modification of SOX4. Conclusion METTL14 overexpression inhibited the proliferation, migration, invasion, and promoted apoptosis in BC cells, and also downregulated the expression of EMT-related proteins, while these effects were abolished by silencing SOX2. This suggests that METTL14, through its influence on SOX4 m6A modification, plays a crucial role in regulating the biological functions of bladder cancer cells, indicating its potential as a therapeutic target for BC.

KEYWORDS

• METTL14
• EMT
• Bladder cancer
• SOX4 mRNA
• m6A

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.58.3.89Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 58, ISSUE 3Inhibiting Cancer Progression through Targeting HDAC2 with Novel Ligands: A Dynamic Insights through Virtual Screening and SimulationAyyub Ali Patel, Hani Alothaid, Ayaz Khurram Mallick, Adel Ibrahim Alalawy, Rasha Tarek Mirdad, Mahmoud Tarek Mirdad, Mohammed Tarek Mirdad, Marya Ahsan, Mohammed Tarique · pp. 802–813Same type: Article
• Article · VOLUME 58, ISSUE 3Anticancer and Hepatoprotective Role of Selenium Nanoparticles against Liver Carcinogen Acrylamide Induced Toxicity: In vitro and in vivo StudiesUzma Faridi, Nahla Zidan, Hebbatallah Atteia, Yahya Al-Awthan, Adel I Alalawy, Md. Qussen Akhtar, Mohamed Sakran, Humaira Parveen · pp. 830–836Same type: Article
• Article · VOLUME 58, ISSUE 3Design and Synthesis of Novel Series of Thiophene-2, 5-dicarbohydrazide Derivatives as Potential Anticancer AgentsVaibhav Gawade, Vitthal Chopade · pp. 837–853Same type: Article
• Article · VOLUME 58, ISSUE 3Lithotriptic Effect of Cinnamomum verum and Nigella sativa on Ureteric CalculiMrinal Sanaye, Nikhat Khan, Dinesh Dhodi, Saleha Parveen · pp. 854–860Same type: Article